BrownA, SusserE. In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev, 8:51–57. 2002.
5.
BuchmanN, StrousRD, UlmanAM, LernerM, KotlerM. Olanzapine-induced leukopenia with human leukocyte antigen profiling. Int Clin Psychopharmacol, 16:55–57. 2001.
6.
ChessS, KornS, FernandezP. Psychiatric Disorders of Children with Congenital Rubella. New York: Brunner/Mazel and London: Buttersworth, 1971.
7.
ChowdhuryNI. Genetics of antipsychotic-induced side effects and agranulocytosis. Curr Psychiatry Rep, 13:156–165. 2011.
8.
DernovsekMZ, TavcarR. Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone. Int Clin Psychopharmacol, 15:237–238. 2000.
9.
Gerbino–RosenG, RoofehD, TompkinsDA, FeryoD, NusserL, KranzlerH, NapolitanoB, FredericksonA., HendersonI, RhinewineJ, KumraS. Hematological adverse events in clozapine-treated children and adolescents. J Am Acad Child Adolesc Psychiatry, 44:1024–1031. 2005.
10.
HussarDA, AbbasCA. New drugs: asenapine, iloperidone, and bepotastine besilate. J Am Pharm Assoc, 50:107–110. 2010.
11.
KonakanchiR, GraceJJ, SzarowiczR, PatoMT. Olanzapine prolongation of granulocytopenia after clozapine discontinuation. J Clin Psychopharmacol, 20:703–704. 2000.
12.
KreyenbuhlJ, DixonL, LoveRC, MedoffD, ConleyRR. Clozapine underutilization and discontinuation in African Americans due to leucopenia. Schizophr Bull, 33:1221–1224. 2007.
13.
MontgomeryJ. Ziprasidone-related agranulocytosis following olanzapine-induced neutropenia. Gen Hosp Psychiatry, 28:83–85. 2006.
14.
RettenbacherMA, HoferA, G., KemmlerG, FleischhackerWW. Neutropenia induced by second generation antipsychotics: A prospective investigation. Pharmacopsychiatry, 43:41–44. 2010.
15.
SayinA, CosarB. Prolongation of clozapine-induced leukopenia with olanzapine treatment. Prog Neuropsychopharmacol Biol Psychiatry, 30:958–959. 2006.
ThangaduraiP, JyothiKS, GoaplakrishnanR, KuruvillaA, JacobKS. Reversible neutropenia with olanzapine following clozapine-induced neutropenia. Am J Psychiatry, 163:7. 2006.
19.
ThomeJ, KopfD. Haematological abnormalities during treatment with atypical antipsychotics. Psychiatry Prax, 32:167–171. 2005.
20.
Tolosa–VilellaC, Ruiz–RipollA, Mari–AlfonsoB, Naval–SendraE. Olanzapine-induced agranulocytosis: a case report and review of the literature. Prog Neuropsychopharmacol Biol Psychiatry, 26:411–414. 2002.
21.
VernonM. Multiply Handicapped Deaf Children: Medical, Educational, Psychological Considerations. Washington, DC: The Council for Exceptional Children, 1969.
22.
WhalenH, MalhotraAK, LenczT, GersonSL, KaneJM, ReedCR. Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis. Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis. J Clin Psychiatry, 72:458–463. 2011.